Table 1. Characteristics of the 33 case-control studies included in the meta-analysis.
Literature sources | HPV(+)/ | HPV(+)/ | Area | Incidence | Detection Method | Control selection | HPV types |
---|---|---|---|---|---|---|---|
cases group | control group | ||||||
Li Y, 1991 | 12/24 | 9/24 | China | Unclear | ISH | Adjacent-normal | 16 |
Han C, 1996 | 22/90 | 6/121 | China | High | ELISA | True-normal | 16 |
Ren ZHP, 1996 | 35/52 | 2/30 | China | Lower | IHC | True-normal | 16,18 |
Wang XJ, 1998 | 20/40 | 36/58 | China | High | ISH | True-normal | 16 |
Lu LC, 1999 | 15/55 | 43/55 | China | High | ISH | Adjacent-normal | 18 |
Cao BW 2005 | 207/265 | 203/357 | China | High | PCR | True-normal | 16, 18 |
Liu J, 2000 | 44/60 | 23/56 | China | High | IHC | True-normal | 16,18 |
Yu DH, 2000 | 78/112 | 42520 | China | Lower | IHC | True-normal | 16,18 |
Kuang ZS, 2000 | 23/56 | 4/56 | China | High | PCR | Adjacent-normal | 16,18 |
Sun LB, 2001 | 42542 | 42390 | China | Lower | PCR-RT | Adjacent-normal | 16 |
Shen ZY, 2002 | 115/176 | 105/176 | China | High | PCR | Adjacent-normal | 6, 11, 16, 18 |
Xu WG, 2003 | 28/40 | 10/50 | China | Unclear | ISH | True-normal | 16 |
Zhou XB, 2003 | 31/48 | 42605 | China | High | PCR | Adjacent-normal | 16 |
Xu CL, 2004 | 16/18 | 126/183 | China | Lower | IHC | Adjacent-normal | 16 |
Lu HS, 2004 | 3/40 | 13/39 | China | Lower | IHC | Adjacent-normal | 16 |
Lu XM, 2004 | 55/104 | 41/104 | China | High | PCR | Adjacent-normal | 16 |
Chen J, 2004 | 14/30 | 7/60 | China | Lower | PCR | True-normal | 16 |
Jiang HY, 2005 | 48/65 | 11/65 | China | Lower | IHC | Adjacent-normal | 16,18 |
Kamangar F, 2006 | 33/99 | 106/381 | China | High | ELISA | True-normal | 16,18,73 |
Zhou SM, 2009 | 26/82 | 10/80 | China | High | PCR | Adjacent-normal | 16 |
Guo F,2012 | 93/300 | 61/900 | China | High | PCR | True-normal | 16,18,58 |
Bahnassy AA, 2005 | 27/50 | 12/50 | Egypt | Unclear | PCR | Adjacent-normal | 16,18,11 |
Benamouzig R, 1992 | 42502 | 42393 | France | Unclear | ISH | True-normal | 6, 11, 16, 18,31, 33, |
Lyronis, 2008 | 17/30 | 42548 | Greece | Unclear | PCR | True-normal | 16,18 |
Farhadi M, 2005 | 14/38 | 5/38 | Iran | High | PCR | True-normal | L1,18 |
Far AE, 2007 | 33/140 | 12/140 | Iranian | Unclear | PCR | Adjacent-normal | 16.18.31.33 |
Astori G, 2001 | 42568 | 42476 | Italy | High | PCR | Adjacent-normal | 16 |
Tornesello ML, 2009 | 12/56 | 42609 | Italy | Unclear | PCR | True-normal | 6,16,8, 15, 20,25 |
Khurshid A, 1998 | 17/27 | 42441 | Japan | Unclear | PCR | True-normal | 16,18,33 |
Kawaguchi H, 2000 | 42721 | 25/58 | Japan and China | Unclear | PCR | True-normal | 16/18 |
Dąbrowski A, 2012 | 28/56 | 4/35 | Lublin | Unclear | PCR | True-normal | 16,18 |
Acevedo, NE, 2004 | 15/17 | 42544 | México | Unclear | PCR | True-normal | 16,11 |
Lagergren J, 1999 | 20/193 | 61/302 | Sweden | Unclear | ELISA | True-normal | 16,18 |
Lower: lower incidence of esophageal carcinoma (EC); Higher: higher incidence of EC; PCR: polymerase chain reaction; IHC: immunohistochemistry; ISH: in situ hybridization; ELISA: enzyme-linked immunosorbent assay. Adjacent-normal: the control group was obtained from the normal marginal tissue of EC during surgery. True-normal: controls were obtained from the normal esophageal epithelial tissue.